621 related articles for article (PubMed ID: 34462336)
1. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
[TBL] [Abstract][Full Text] [Related]
2. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
[TBL] [Abstract][Full Text] [Related]
3. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
4. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
[TBL] [Abstract][Full Text] [Related]
6. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
7. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
8. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
9. Significance of the gut microbiome in multistep colorectal carcinogenesis.
Mizutani S; Yamada T; Yachida S
Cancer Sci; 2020 Mar; 111(3):766-773. PubMed ID: 31910311
[TBL] [Abstract][Full Text] [Related]
10. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer.
Gao W; Gao X; Zhu L; Gao S; Sun R; Feng Z; Wu D; Liu Z; Zhu R; Jiao N
Gut Microbes; 2023 Dec; 15(2):2245562. PubMed ID: 37635357
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.
Zwezerijnen-Jiwa FH; Sivov H; Paizs P; Zafeiropoulou K; Kinross J
Neoplasia; 2023 Feb; 36():100868. PubMed ID: 36566591
[TBL] [Abstract][Full Text] [Related]
12. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
13. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
14. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
15. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.
Clos-Garcia M; Andrés-Marin N; Fernández-Eulate G; Abecia L; Lavín JL; van Liempd S; Cabrera D; Royo F; Valero A; Errazquin N; Vega MCG; Govillard L; Tackett MR; Tejada G; Gónzalez E; Anguita J; Bujanda L; Orcasitas AMC; Aransay AM; Maíz O; López de Munain A; Falcón-Pérez JM
EBioMedicine; 2019 Aug; 46():499-511. PubMed ID: 31327695
[TBL] [Abstract][Full Text] [Related]
16. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.
Du X; Li Q; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Chen G; Yue H; Li J; Zhao M; Han YP; Fu X
Front Physiol; 2022; 13():854545. PubMed ID: 35600308
[No Abstract] [Full Text] [Related]
18. An integrated analysis of the fecal metabolome and metagenome reveals the distinct effects of differentially charged nanoplastics on the gut microbiota-associated metabolites in mice.
Teng M; Zhao X; Zhou L; Yan H; Zhao L; Sun J; Li Y; Zhu W; Wu F
Sci Total Environ; 2024 Jan; 906():167287. PubMed ID: 37748599
[TBL] [Abstract][Full Text] [Related]
19. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.
Xi Y; Yuefen P; Wei W; Quan Q; Jing Z; Jiamin X; Shuwen H
J Transl Med; 2019 Oct; 17(1):353. PubMed ID: 31665031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
